1. Peng Z, Wang H, Zheng J, et al. Is the proximal tubule the focus of tubulointerstitial fibrosis? Heliyon 2023;9:e13508.
2. Rende U, Guller A, Goldys EM, et al. Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. J Physiol 2023;601:2801–2826.
3. Zhang Y, Tao C, Xuan C, et al. Transcriptomic analysis reveals the protection of astragaloside IV against diabetic nephropathy by modulating inflammation. Oxid Med Cell Longev 2020;2020:9542165.
4. Ling Y, Jing C, Luqi Q. Exploring the mechanism of Yishen Huoxue Formula in treating renal fibrosis based on network pharmacology and experimental validation. Cent South Pharm (Chin) 2023;21:1786–1793.
5. Li SJ, Zhang SY, Li X, et al. Research progress on the treatment of hypertensive neuropathy with Huangqi. Chin Arch Tradit Chin Med (Chin) 2023;42:1–12.